Felodipineextended-release Tablets
Product Images NDC 63304-435

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Felodipineextended-release Tablets (NDC 63304-435). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ranbaxy Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100's_bottlle_label (Felo Tabs 10)

This is a prescription medication called Felodipine. It comes in the form of extended-release tablets with a strength of 100 tablets. The usual adult dosage is not provided, so the package insert should be consulted. The package is not for dispensing and should be kept out of direct sunlight and stored below 30°C (85°F). The tablets should be swallowed whole, not chewed or crushed. It was manufactured for Ranbaxy Pharmaceuticals in Jacksonville, FL, USA, by Mork & Co. Inc. The product code is 63304-437-01 and the tablet has the label number NG 63304-437-01.*

FDA Label Image

100''s_bottle_label (Felo Tabs 2.5)

This is a product package for Felodipine, extended-release tablets. It contains information such as the dosage, storage guidelines, and manufacturing details. The tablets should be swallowed whole and not chewed or crushed. The package is not intended for dispensing. It is manufactured for Ranbay Pharmaceuticals by Merck & Co. The text also includes a product code: NDG 63304435-01, and a warning to protect the product from light.*

FDA Label Image

100's_bottle_label (Felo Tabs 5)

FDA Label Image

Mol_strr (Mol Strr)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.